Company: SCLXW
Filing Date: 2025-12-16
Form Type: S-1
Source: 0001193125-25-319720
Chunk: 219

Company: Scilex Holding Co
Filing Date: 2025-12-16
Form: S-1
Chunk 219
---
   |
| Other                                   |     |                                 |  4,879 |     |      |     — |     |            | 4,879 |   |
| Total R&D Discovery Project             |     |                                 |  5,109 |     |      |     — |     |            | 5,109 |   |
| Total Research and Development Expenses |     |                               $ | 12,542 |     |    $ | 7,461 |     | $          | 5,081 |   |

**Research and development expenses for the nine months ended September 30, 2025 and 2024 were $12.5 million and $7.5 million, respectively. The increase was primarily attributed to additional expenses related to KDS2010 to Scilex Bio. Selling, General and Administrative Expenses Selling, general and administrative expenses for the nine months ended September 30, 2025 and 2024 were $236.7 million and $83.6 million, respectively. The increase of approximately $153.1 million was primarily due to a $140.0 million increase related to issuance costs for reverse recapitalization with Denali, a $23.7 million increase in advisory and financing expenses, a $3.4 million increase in contracted services, a $1.8 million increase related to issuance costs for September 2025 Warrants, a $3.0 million increase in expense related to the shares of Common Stock issuable to Tumim in connection with the Company’s equity line of credit with Tumim and a $1.1 million increase in other expenses, partially offset by a $5.5 million decrease in rebate expenses primarily related to future shipments of the Additional Product under the Satisfaction Agreement, a $4.8 million decrease in marketing expenses, a $4.7 million decrease in personnel expense, a $2.9 million decrease in travel expenses, a $1.2 million decrease in allowances for expected credit losses on accounts receivable, a $0.7 million decrease in insurance costs and a $0.1 million increase in legal fees in the nine months ended September 30, 2025. Intangible Amortization Expense Intangible amortization expense for each of the nine months ended September 30, 2025 and 2024 was $3.0 million. Legal Settlements Legal settlements for the nine months ended September 30, 2025 and 2024 were $0.1 million and $9.4